TY - CONF
T1 - Provision of scheduled outpatient consultations for patients with non-communicable diseases during the COVID-19 emergency in spring 2020 in Latvia
AU - Behmane, Daiga
AU - Strēle, Ieva
AU - Kursīte, Mirdza
AU - Gobiņa, Inese
AU - Dūdele, Alina
AU - Avotiņš, Andris
AU - Villeruša, Anita
N1 - Conference code: 8
PY - 2021/3/24
Y1 - 2021/3/24
N2 - The study aimed to assess the changes in provision of the total and remote consultations by family physicians and specialists during scheduled on-site outpatient consulting suspension (except for oncological patients) due to the COVID-19 emergency in Spring 2020. The study was carried out in the frame of the National research programme project VPP-COVID-2020/1-0011. Data from the National Health Service for selected non-communicable diseases were analyzed, including diseases with suspended on-site consultations for diabetes (E10; E11), cardiovascular diseases (CVD) (I10; I20-I25; I50), asthma (J44; J45), and oncological diseases with ongoing on-site consultations (breast (C50) and prostate cancer (C61)).
Proportionate 2020 weekly consultation volume against 2019 was assessed, and its average for 13th-16th week was calculated, as well as remote consultation proportion out of total. On average, during 13th-16th
week the largest decrease of consultation volume was seen for both family physicians and specialists, respectively: 63.1% and 76.6% for diabetes, 74.8% and 29.7% for CVD, 85.3% and 35.1% for asthma, 80.2% and 110.0% for breast cancer, 71.6% and 68.8% for prostate cancer.
During 13th-16th
week a gradual increase of remote consultation proportion was seen in all groups of diagnosis both for family physicians and specialists, respectively: 47.1% and 85.2% for diabetes, 53.4% and 63.3% for CVD, 44.9% and 67.4% for asthma, 40.5% and 38.9% for breast cancer, 36.4% and 23.9% for prostate cancer at the highest point during the period. A reduction of total consultation volume in 2020 compared with 2019 was observed for all groups of diagnosis and for both family physicians and specialists, including oncological diseases, with one exception – specialists’ consultations for breast cancer patients. On-site consultations partly were replaced with remote consultations, but without the capacity to compensate for the total decrease. Further research is needed on remote consultation implementation as a valuable tool and their sustainable provision.
AB - The study aimed to assess the changes in provision of the total and remote consultations by family physicians and specialists during scheduled on-site outpatient consulting suspension (except for oncological patients) due to the COVID-19 emergency in Spring 2020. The study was carried out in the frame of the National research programme project VPP-COVID-2020/1-0011. Data from the National Health Service for selected non-communicable diseases were analyzed, including diseases with suspended on-site consultations for diabetes (E10; E11), cardiovascular diseases (CVD) (I10; I20-I25; I50), asthma (J44; J45), and oncological diseases with ongoing on-site consultations (breast (C50) and prostate cancer (C61)).
Proportionate 2020 weekly consultation volume against 2019 was assessed, and its average for 13th-16th week was calculated, as well as remote consultation proportion out of total. On average, during 13th-16th
week the largest decrease of consultation volume was seen for both family physicians and specialists, respectively: 63.1% and 76.6% for diabetes, 74.8% and 29.7% for CVD, 85.3% and 35.1% for asthma, 80.2% and 110.0% for breast cancer, 71.6% and 68.8% for prostate cancer.
During 13th-16th
week a gradual increase of remote consultation proportion was seen in all groups of diagnosis both for family physicians and specialists, respectively: 47.1% and 85.2% for diabetes, 53.4% and 63.3% for CVD, 44.9% and 67.4% for asthma, 40.5% and 38.9% for breast cancer, 36.4% and 23.9% for prostate cancer at the highest point during the period. A reduction of total consultation volume in 2020 compared with 2019 was observed for all groups of diagnosis and for both family physicians and specialists, including oncological diseases, with one exception – specialists’ consultations for breast cancer patients. On-site consultations partly were replaced with remote consultations, but without the capacity to compensate for the total decrease. Further research is needed on remote consultation implementation as a valuable tool and their sustainable provision.
M3 - Abstract
SP - 21
T2 - RSU Research week 2021: Society. Health. Welfare
Y2 - 24 March 2021 through 26 March 2021
ER -